Literature DB >> 12409449

A versatile communication module for controlling RNA folding and catalysis.

Alexis Kertsburg1, Garrett A Soukup.   

Abstract

To exert control over RNA folding and catalysis, both molecular engineering strategies and in vitro selection techniques have been applied toward the development of allosteric ribozymes whose activities are regulated by the binding of specific effector molecules or ligands. We now describe the isolation and characterization of a new and considerably versatile RNA element that functions as a communication module to render disparate RNA folding domains interdependent. In contrast to some existing communication modules, the novel 9-nt RNA element is demonstrated to function similarly between a variety of catalysts that include the hepatitis delta virus, hammerhead, X motif and Tetrahymena group I ribozymes, and various ligand-binding domains. The data support a mechanistic model of RNA folding in which the element is comprised of both canonical and non-canonical base pairs and an unpaired nucleotide in the active, effector-bound conformation. Aside from enabling effector-controlled RNA function through rational design, the element can be utilized to identify sites in large RNAs that are susceptible to effector regulation.

Mesh:

Substances:

Year:  2002        PMID: 12409449      PMCID: PMC135812          DOI: 10.1093/nar/gkf596

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  44 in total

1.  Maxizymes, novel allosterically controllable ribozymes, can be designed to cleave various substrates.

Authors:  T Tanabe; I Takata; T Kuwabara; M Warashina; H Kawasaki; K Tani; S Ohta; S Asano; K Taira
Journal:  Biomacromolecules       Date:  2000       Impact factor: 6.988

2.  A general approach for the use of oligonucleotide effectors to regulate the catalysis of RNA-cleaving ribozymes and DNAzymes.

Authors:  Dennis Y Wang; Beatrice H Y Lai; Anat R Feldman; Dipankar Sen
Journal:  Nucleic Acids Res       Date:  2002-04-15       Impact factor: 16.971

Review 3.  Engineered allosteric ribozymes as biosensor components.

Authors:  Ronald R Breaker
Journal:  Curr Opin Biotechnol       Date:  2002-02       Impact factor: 9.740

4.  Monitoring post-translational modification of proteins with allosteric ribozymes.

Authors:  Narendra K Vaish; Fang Dong; Lori Andrews; Rebecca E Schweppe; Natalie G Ahn; Lawrence Blatt; Scott D Seiwert
Journal:  Nat Biotechnol       Date:  2002-07-15       Impact factor: 54.908

5.  Protein-dependent ribozymes report molecular interactions in real time.

Authors:  Jörg S Hartig; S Hani Najafi-Shoushtari; Imke Grüne; Amy Yan; Andrew D Ellington; Michael Famulok
Journal:  Nat Biotechnol       Date:  2002-07       Impact factor: 54.908

6.  Self-cleavage of hepatitis delta virus genomic strand RNA is enhanced under partially denaturing conditions.

Authors:  S P Rosenstein; M D Been
Journal:  Biochemistry       Date:  1990-09-04       Impact factor: 3.162

7.  Self-cleavage of plus and minus RNAs of a virusoid and a structural model for the active sites.

Authors:  A C Forster; R H Symons
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

Review 8.  Self-splicing of group I introns.

Authors:  T R Cech
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

9.  Allosterically controllable maxizyme-mediated suppression of progression of leukemia in mice.

Authors:  T Kuwabara; T Tanabe; M Warashina; K X Xiong; K Tani; K Taira; S Asano
Journal:  Biomacromolecules       Date:  2001       Impact factor: 6.988

10.  Human hepatitis delta virus RNA subfragments contain an autocleavage activity.

Authors:  H N Wu; Y J Lin; F P Lin; S Makino; M F Chang; M M Lai
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

View more
  11 in total

Review 1.  Rube Goldberg goes (ribo)nuclear? Molecular switches and sensors made from RNA.

Authors:  Scott K Silverman
Journal:  RNA       Date:  2003-04       Impact factor: 4.942

2.  A general method for rapid and nondenaturing purification of RNAs.

Authors:  Jeffrey S Kieft; Robert T Batey
Journal:  RNA       Date:  2004-06       Impact factor: 4.942

3.  A modular and extensible RNA-based gene-regulatory platform for engineering cellular function.

Authors:  Maung Nyan Win; Christina D Smolke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-20       Impact factor: 11.205

4.  Competitive regulation of modular allosteric aptazymes by a small molecule and oligonucleotide effector.

Authors:  S Hani Najafi-Shoushtari; Michael Famulok
Journal:  RNA       Date:  2005-10       Impact factor: 4.942

Review 5.  Engineering ligand-responsive gene-control elements: lessons learned from natural riboswitches.

Authors:  K H Link; R R Breaker
Journal:  Gene Ther       Date:  2009-07-09       Impact factor: 5.250

6.  A novel strategy for selection of allosteric ribozymes yields RiboReporter sensors for caffeine and aspartame.

Authors:  Alicia Ferguson; Ryan M Boomer; Markus Kurz; Sara C Keene; John L Diener; Anthony D Keefe; Charles Wilson; Sharon T Cload
Journal:  Nucleic Acids Res       Date:  2004-03-16       Impact factor: 16.971

7.  Bis-aptazyme sensors for hepatitis C virus replicase and helicase without blank signal.

Authors:  Suhyung Cho; Ji-Eun Kim; Bo-Rahm Lee; June-Hyung Kim; Byung-Gee Kim
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

Review 8.  Modulating RNA structure and catalysis: lessons from small cleaving ribozymes.

Authors:  Cedric Reymond; Jean-Denis Beaudoin; Jean-Pierre Perreault
Journal:  Cell Mol Life Sci       Date:  2009-08-30       Impact factor: 9.261

Review 9.  Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors.

Authors:  Zachary J Tickner; Michael Farzan
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-10

10.  Controlling mammalian gene expression by allosteric hepatitis delta virus ribozymes.

Authors:  Yoko Nomura; Linlin Zhou; Anh Miu; Yohei Yokobayashi
Journal:  ACS Synth Biol       Date:  2013-05-22       Impact factor: 5.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.